Veradermics, Inc. (MANE)
106.14
-1.71
(-1.59%)
USD |
NYSE |
May 08, 16:00
105.84
-0.30
(-0.28%)
After-Hours: 20:00
Veradermics EPS Diluted (Quarterly) : -0.7554 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Organon & Co. | 0.5554 |
| Merck & Co., Inc. | -1.715 |
| Bristol Myers Squibb Co. | 1.308 |
| Terns Pharmaceuticals, Inc. | -0.2395 |
| Corcept Therapeutics, Inc. | -0.2988 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.85M |
| Total Expenses (Quarterly) | 21.85M |
| Enterprise Value | 4.088B |
| Earnings Yield | -0.89% |